Autonomous Diagnostics to Enable Prevention and Therapeutics: Prophylactic Options to Environmental and Contagious Threats (ADEPT-PROTECT)

Archived

DARPA - Defense Sciences Office

View on Grants.gov 📝 Build a proposal template ★ Save

Description

DARPA is soliciting proposals for the development of nucleic acid platforms capable of in vivo host production of a transient immune prophylaxis for adults as a component of the Autonomous Diagnostics to Enable Prevention and Therapeutics (ADEPT) program.See attached DARPA-BAA-13-03.

Who can apply

  • Unrestricted

Contact

DARPA BAA Coordinator
DARPA-BAA-13-03@darpa.mil

Key dates & funding
  • PostedNov 1, 2012
  • ClosesJan 15, 2013
  • CFDA12.910
Categories
Science and Technology and other Research and Development

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro